<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Antibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosis - Waters, V - 2020 | Cochrane Library</title> <meta content="Antibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosis - Waters, V - 2020 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010004.pub5/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Antibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosis - Waters, V - 2020 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010004.pub5/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD010004.pub5" name="dc.identifier" scheme="DOI"/> <meta content="Antibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosis" name="citation_title"/> <meta content="Valerie Waters" name="citation_author"/> <meta content="Hospital for Sick Children" name="citation_author_institution"/> <meta content="valerie.waters@sickkids.ca" name="citation_author_email"/> <meta content="Felix Ratjen" name="citation_author"/> <meta content="The Hospital for Sick Children" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="6" name="citation_issue"/> <meta content="10.1002/14651858.CD010004.pub5" name="citation_doi"/> <meta content="2020" name="citation_date"/> <meta content="2020/06/10" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010004.pub5/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010004.pub5/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010004.pub5/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Anti-Bacterial Agents [*therapeutic use]; Cystic Fibrosis [*microbiology]; Drug Therapy, Combination [methods]; Lung Diseases [*drug therapy, microbiology]; Mycobacterium abscessus; Mycobacterium avium Complex; Mycobacterium Infections, Nontuberculous [*drug therapy]; Nontuberculous Mycobacteria" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010004.pub5&amp;doi=10.1002/14651858.CD010004.pub5&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010004.pub5&amp;doi=10.1002/14651858.CD010004.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010004.pub5&amp;doi=10.1002/14651858.CD010004.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010004.pub5&amp;doi=10.1002/14651858.CD010004.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010004.pub5&amp;doi=10.1002/14651858.CD010004.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010004.pub5&amp;doi=10.1002/14651858.CD010004.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010004.pub5&amp;doi=10.1002/14651858.CD010004.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010004.pub5&amp;doi=10.1002/14651858.CD010004.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010004.pub5&amp;doi=10.1002/14651858.CD010004.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010004.pub5&amp;doi=10.1002/14651858.CD010004.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010004.pub5&amp;doi=10.1002/14651858.CD010004.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010004.pub5&amp;doi=10.1002/14651858.CD010004.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010004.pub5&amp;doi=10.1002/14651858.CD010004.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010004.pub5&amp;doi=10.1002/14651858.CD010004.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010004.pub5&amp;doi=10.1002/14651858.CD010004.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010004.pub5&amp;doi=10.1002/14651858.CD010004.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010004.pub5&amp;doi=10.1002/14651858.CD010004.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010004.pub5&amp;doi=10.1002/14651858.CD010004.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010004.pub5&amp;doi=10.1002/14651858.CD010004.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010004.pub5&amp;doi=10.1002/14651858.CD010004.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010004.pub5&amp;doi=10.1002/14651858.CD010004.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010004.pub5&amp;doi=10.1002/14651858.CD010004.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010004.pub5&amp;doi=10.1002/14651858.CD010004.pub5&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774054000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774081000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000"}};Liferay.authToken="bzu3XIhG";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD010004\x2epub5\x26doi\x3d10\x2e1002\x2f14651858\x2eCD010004\x2epub5\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010004\x2epub5\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010004\x2epub5\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1559916434000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","zh_HANS","zh_HANT","ko","ms","fa","fr"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD010004.pub5",title:"Antibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosis",firstPublishedDate:"Jun 10, 2020 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Cystic Fibrosis and Genetic Disorders Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738735355000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=bzu3XIhG&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010004.pub5&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD010004.pub5';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD010004.pub5/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD010004.pub5/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010004.pub5%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD010004.pub5/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD010004.pub5/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD010004.pub5/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD010004.pub5/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD010004.PUB5" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;초록&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;쉬운 말 요약&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;},{&quot;language&quot;:&quot;zh_HANT&quot;,&quot;title&quot;:&quot;淺顯易懂的口語結論&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD010004.pub5/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD010004.PUB5" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD010004.pub5/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD010004.pub5/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>14455 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD010004.pub5" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010004.pub5/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010004.pub5/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010004.pub5/full#CD010004-abs-0002"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010004.pub5/full#CD010004-sec-0056"> Authors' conclusions </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010004.pub5/full#CD010004-sec-0008"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010004.pub5/full#CD010004-sec-0013"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010004.pub5/full#CD010004-sec-0014"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010004.pub5/full#CD010004-sec-0045"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010004.pub5/full#CD010004-sec-0052"> Discussion </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010004.pub5/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010004.pub5/references#characteristicStudies"> Characteristics of studies </a> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010004.pub5/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010004.pub5/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010004.pub5/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD010004.pub5/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD010004.pub5/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD010004.pub5/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2020 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD010004.pub5/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> <div class="inline-status-wrapper"> <ul class="cochrane-status"> <li aria-label="A new search for studies has been conducted." class="status-item up-to-date custom-tooltip" data-status="newsearch" title="A new search for studies has been conducted."> <a class="btn secondary" href="information#history">New search</a> </li> </ul> </div> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Antibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosis </h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010004.pub5/information#CD010004-cr-0004"><i class="icon corresponding-author fa fa-envelope"></i>Valerie Waters</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010004.pub5/information#CD010004-cr-0005">Felix Ratjen</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD010004.pub5/information/en#CD010004-sec-0063">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 10 June 2020 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD010004.pub5/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD010004.pub5">https://doi.org/10.1002/14651858.CD010004.pub5</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD010004-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD010004-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD010004-abs-0013">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD010004-abs-0009">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD010004-abs-0011">Français</a> </li> <li class="section-language"> <a class="" href="full/ko#CD010004-abs-0006">한국어</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD010004-abs-0003">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD010004-abs-0001" lang="en"> <section id="CD010004-sec-0001"> <h3 class="title" id="CD010004-sec-0001">Background</h3> <p>Nontuberculous mycobacteria are mycobacteria, other than those in the <i>Mycobacterium tuberculosis</i> complex, and are commonly found in the environment. Nontuberculous mycobacteria species (most commonly <i>Mycobacterium avium</i> complex and <i>Mycobacterium abscessus</i>) are isolated from the respiratory tract of approximately 5% to 40% of individuals with cystic fibrosis; they can cause lung disease in people with cystic fibrosis leading to more a rapid decline in lung function and even death in certain circumstances. Although there are guidelines for the antimicrobial treatment of nontuberculous mycobacteria lung disease, these recommendations are not specific for people with cystic fibrosis and it is not clear which antibiotic regimen may be the most effective in the treatment of these individuals. This is an update of a previous review. </p> </section> <section id="CD010004-sec-0002"> <h3 class="title" id="CD010004-sec-0002">Objectives</h3> <p>The objective of our review was to compare antibiotic treatment to no antibiotic treatment, or to compare different combinations of antibiotic treatment, for nontuberculous mycobacteria lung infections in people with cystic fibrosis. The primary objective was to assess the effect of treatment on lung function and pulmonary exacerbations and to quantify adverse events. The secondary objectives were to assess treatment effects on the amount of bacteria in the sputum, quality of life, mortality, nutritional parameters, hospitalizations and use of oral antibiotics. </p> </section> <section id="CD010004-sec-0003"> <h3 class="title" id="CD010004-sec-0003">Search methods</h3> <p>We searched the Cochrane Cystic Fibrosis Trials Register, compiled from electronic database searches and hand searching of journals and conference abstract books. Date of last search: 24 February 2020. </p> <p>We also searched a register of ongoing trials and the reference lists of relevant articles and reviews. Date of last search: 21 March 2019. </p> </section> <section id="CD010004-sec-0004"> <h3 class="title" id="CD010004-sec-0004">Selection criteria</h3> <p>Any randomized controlled trials comparing nontuberculous mycobacteria antibiotics to no antibiotic treatment, as well as one nontuberculous mycobacteria antibiotic regimen compared to another nontuberculous mycobacteria antibiotic regimen, in individuals with cystic fibrosis.   </p> </section> <section id="CD010004-sec-0005"> <h3 class="title" id="CD010004-sec-0005">Data collection and analysis</h3> <p>Data were not collected because in the one trial identified by the search, data specific to individuals with cystic fibrosis could not be obtained from the pharmaceutical company. </p> </section> <section id="CD010004-sec-0006"> <h3 class="title" id="CD010004-sec-0006">Main results</h3> <p>One completed trial was identified by the searches, but data specific to individuals with cystic fibrosis could not be obtained from the pharmaceutical company. </p> </section> <section id="CD010004-sec-0007"> <h3 class="title" id="CD010004-sec-0007">Authors' conclusions</h3> <p>This review did not find any evidence for the effectiveness of different antimicrobial treatment for nontuberculous mycobacteria lung disease in people with cystic fibrosis. Until such evidence becomes available, it is reasonable for clinicians to follow published clinical practice guidelines for the diagnosis and treatment of nodular or bronchiectatic pulmonary disease due to <i>Mycobacterium avium</i> complex or <i>Mycobacterium abscessus</i> in patients with cystic fibrosis. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD010004-abs-0002" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD010004-abs-0002">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD010004-abs-0014">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD010004-abs-0010">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD010004-abs-0012">Français</a> </li> <li class="section-language"> <a class="" href="full/ko#CD010004-abs-0007">한국어</a> </li> <li class="section-language"> <a class="" href="full/ms#CD010004-abs-0008">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD010004-abs-0004">简体中文</a> </li> <li class="section-language"> <a class="" href="full/zh_HANT#CD010004-abs-0005">繁體中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD010004-abs-0002" lang="en"> <h3>Antibiotic treatment for nontuberculous mycobacteria in people with cystic fibrosis </h3> <p>Nontuberculous mycobacteria are bacteria that are in the same family as tuberculosis and are commonly found in the soil and water. These bacteria can be found in the lungs of people with cystic fibrosis and can cause their lung function to worsen. Although there are guidelines on which antibiotics to use to treat lung infection due to these bacteria, these recommendations are not specific for people with cystic fibrosis. It is also not clear which are the most effective antibiotics. The main purpose of this review was to determine whether treatment with different antibiotic combinations for nontuberculous mycobacterial infection would improve lung function or decrease the frequency of chest infections in people with cystic fibrosis. We found one randomized controlled trial but it included both people with and without cystic fibrosis and we could not get the information specifically about individuals with cystic fibrosis so could not include the information in this review. Until the time when such information is available, clinicians should follow the current guidelines for the diagnosis and treatment of lung infections due to nontuberculous mycobacteria in the general population. </p> <p><b>Review question</b> </p> <p>We reviewed the evidence about using antibiotics to treat nontuberculous mycobacteria infection in people with cystic fibrosis. </p> <p><b>Background</b> </p> <p>Nontuberculous mycobacteria are bacteria that are from the same family as tuberculosis and are commonly found in the soil and water. These bacteria can be found in the lungs of people with cystic fibrosis and may cause their lung function to worsen. Although there are guidelines on which antibiotics to use to treat lung infection due to these bacteria, these recommendations are not specifically for people with cystic fibrosis. It is also not clear which antibiotics work best. The main aim of this review was to show whether or not treating nontuberculous mycobacterial infection with different combinations of antibiotics improves lung function or decreases the frequency of chest infections in people with cystic fibrosis. </p> <p><b>Search date</b> </p> <p>The evidence is current to: 24 February 2020.</p> <p><b>Study characteristics</b> </p> <p>We found one randomized controlled trial but it included both people with and without cystic fibrosis and we could not get the information specifically about individuals with cystic fibrosis so could not include the information in this review. </p> <p><b>Key results</b> </p> <p>Until the time when randomized controlled trial data is available for individuals with cystic fibrosis, clinicians should follow the current guidelines for the diagnosis and treatment of lung infections due to nontuberculous mycobacteria in the general population.  </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD010004-sec-0056" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD010004-sec-0056"></div> <h3 class="title" id="CD010004-sec-0057">Implications for practice</h3> <section id="CD010004-sec-0057"> <p>This review did not find any evidence from randomized controlled trials of the effectiveness of different antimicrobial treatment for nontuberculous mycobacteria (NTM) lung disease in people with cystic fibrosis (CF). Until such evidence becomes available, it is reasonable for clinicians to follow clinical practice guidelines for the management of NTM pulmonary infections in individuals with CF. The Cystic Fibrosis Foundation and the European Cystic Fibrosis Society have recently issued a consensus guideline for the screening, investigation, diagnosis and treatment of individuals with CF and NTM pulmonary disease due to <i>Mycobacteria avium</i> complex or <i>Mycobacteria abscessus</i> (<a href="./references#CD010004-bbs2-0025" title="FlotoRA , OlivierKN , SaimanL , DaleyCL , HerrmannJL , NickJA , et al. US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis: executive summary. Thorax2016;71(1):88-90.">Floto 2016</a>). The antibiotic treatment regimens are generally complex due to the long treatment durations and high frequency of associated side effects; consultation with specialists in the field is generally recommended. </p> </section> <h3 class="title" id="CD010004-sec-0058">Implications for research</h3> <section id="CD010004-sec-0058"> <p>Given the high prevalence of NTM pulmonary infection in certain CF centers and the concern of adverse effect of <i>M abscessus</i> on lung function in young children, properly‐designed and adequately‐powered randomized controlled trials are needed to determine if antibiotic treatment of NTM species improves clinical outcomes, such as forced expiratory volume in one second (FEV<sub>1</sub>), in people with CF. However, properly conducted randomized controlled interventional trials are difficult to undertake in this population as there are many potential confounding variables that can affect lung function. In addition, these trials may require large sample sizes to detect significant changes in FEV<sub>1</sub>. Prospective observational studies of the diagnosis (PREDICT Trial (<a href="./references#CD010004-bbs2-0043" title="NCT02073409. PREDICT Trial: PRospective Evaluation of NTM Disease In CysTic Fibrosis (PREDICT). clinicaltrials.gov/ct2/show/NCT02073409 (first received 24 February 2014.">NCT02073409</a>)) and algorithms for the treatment (PATIENCE Trial (<a href="./references#CD010004-bbs2-0044" title="NCT02419989. PATIENCE Trial: Prospective Algorithm for Treatment of NTM in Cystic Fibrosis (PATIENCE). clinicaltrials.gov/ct2/show/NCT02419989 (first received: 09 December 2014).">NCT02419989</a>)) of NTM infections in CF are also being conducted with outcome measures including microbiological eradication, lung function and nutritional status changes and frequency of pulmonary exacerbations. Although not randomized controlled trials, such data may help guide the future management of individuals with CF with this type of infection. </p> </section> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD010004-sec-0008" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD010004-sec-0008"></div> <section id="CD010004-sec-0009"> <h3 class="title" id="CD010004-sec-0009">Description of the condition</h3> <p>Although cystic fibrosis (CF) is the most common life‐shortening genetic disease in people of Northern European descent (<a href="./references#CD010004-bbs2-0023" title="FarrellP , FérecC , MacekM , FrischerT , RennerS , RissK , et al. Estimating the age of p.(Phe508del) with family studies of geographically distinct European populations and the early spread of cystic fibrosis. European Journal of Human Genetics 2018 Aug 08 [Epub ahead of print]. [DOI: 10.1038/s41431-018-0234-z]">Farrell 2018</a>), there has been a dramatic improvement in the median survival age of individuals with CF over the past several decades (<a href="./references#CD010004-bbs2-0013" title="Cystic Fibrosis Foundation. Patient Registry Report 2013. www.cff.org/LivingWithCF/QualityImprovement/PatientRegistryReport/# (accessed 29 October 2012).">CF Foundation 2013</a>; <a href="./references#CD010004-bbs2-0012" title="Cystic Fibrosis Canada. Patient Data Registry Report 2014. www.cysticfibrosis.ca/assets/files/pdf/cpdr_reporte.pdf (accessed 29 October 2012).">CF Canada 2014</a>; <a href="./references#CD010004-bbs2-0029" title="GibsonRL , BurnsJL , RamseyBW . Pathophysiology and management of pulmonary infections in cystic fibrosis. American Journal of Respiratory and Critical Care Medicine2003;168(8):918-51. [PMID: 14555458]">Gibson 2003</a>). As people with CF live longer, they are more likely to become colonized with environmental organisms such as nontuberculous mycobacteria (NTM). </p> <p>NTM are mycobacteria other than those in the <i>Mycobacterium tuberculosis</i> complex, which includes <i>M tuberculosis</i> (<a href="./references#CD010004-bbs2-0039" title="MandellGL , BennettJE , DolinR . Principles and Practice of Infectious Diseases. Seventh edition. Philadephia: Churchill Livingstone Elsevier, 2010.">Mandell 2010</a>). They are commonly found in the environment and have been isolated from soil, water, animals, plants and birds (<a href="./references#CD010004-bbs2-0022" title="FalkinhamJO , NortonCD , LechevallierMW . Factors influencing numbers of Mycobacterium avium, Mycobacterium intracellulare and other Mycobacteria in drinking water distribution systems. Applied and Environmental Microbiology2001;67(3):1225-31. [PMID: 11229914]">Falkinham 2001</a>). Species of NTM can cause disease, such as lymphadenitis and bronchopulmonary infection, in both immunocompromised as well as immunocompetent people (<a href="./references#CD010004-bbs2-0039" title="MandellGL , BennettJE , DolinR . Principles and Practice of Infectious Diseases. Seventh edition. Philadephia: Churchill Livingstone Elsevier, 2010.">Mandell 2010</a>). </p> <p>In the 1990s, NTM species began to be regularly cultured from the respiratory tract of individuals with CF around the world. Data from the Canadian and American Patient Registries estimates the prevalence of NTM infection (at least one positive culture in the prior year) between 5% and 20% of all people with CF (<a href="./references#CD010004-bbs2-0014" title="Cystic Fibrosis Canada. The Canadian cystic fibrosis registry 2016 annual data report. www.cysticfibrosis.ca/uploads/2016%20Registry%20Annual%20Data%20Report.pdf (accessed 21 March 2019).">CFC 2016</a>; <a href="./references#CD010004-bbs2-0015" title="Cystic Fibrosis Foundation. 2016 patient registry annual data report. www.cff.org/research/researcher-resources/patient-registry/2016-patient-registry-annual-data-report.pdf (accessed 21 March 2019).">CFF 2016</a>). The 2010‐2014 CF Patient Registry reported that 61% of NTM infections were due to <i>M. avium</i> complex, whereas the remaining 39% were due to <i>M. abscessus</i> complex (<a href="./references#CD010004-bbs2-0004" title="AdjemianJ , OlivierKN , PrevotsDR . Epidemiology of pulmonary nontuberculous mycobacterial sputum positivity in patients with cystic fibrosis in the United States, 2010-2014. Annals of the American Thoracic Society2018;15(7):817-26.">Adjemian 2018</a>).The <i>M avium</i> complex consists of <i>M avium</i> and <i>M intracellulare</i> (<a href="./references#CD010004-bbs2-0039" title="MandellGL , BennettJE , DolinR . Principles and Practice of Infectious Diseases. Seventh edition. Philadephia: Churchill Livingstone Elsevier, 2010.">Mandell 2010</a>) and the <i>M abscessus</i> complex is generally accepted to consist of <i>M abscessus</i> , <i>M bolletii</i> and <i>M massiliense</i> (<a href="./references#CD010004-bbs2-0007" title="Blauwendraat C,  DixonGL ,  HartleyJC ,  FowerakerJ ,  HarrisKA . The use of a two-gene sequencing approach to accurately distinguish between the species within the Mycobacterium abscessus complex and Mycobacterium chelonae. European Journal of Clinical Microbiology and Infectious Diseases2012;31(8):1847-53.">Blauwendraat 2012</a>; <a href="./references#CD010004-bbs2-0059" title="TortoliE , KohlTA , Brown-ElliottBA , TrovatoA , Cardoso LeaoS , GarciaMJ , et al. Emended description of Mycobacterium abscessus, Mycobacterium abscessus subs. abscessus, Mycobacterium abscessus subsp. bolletii and designation of Mycobacterium abscessus subsp. massiliense comb. nov. International Journal of Systematic and Evolutionary Microbiology2016;66(11):4471-9.">Tortoli 2016</a>). People with CF who have <i>M avium</i> complex tend to be older, have better lung function, have a higher rate of <i>Staphylococcus aureus</i> and a lower rate of <i>Pseudomonas aeruginosa</i> infection, suggesting a healthy survivorship effect in colonized individuals (<a href="./references#CD010004-bbs2-0045" title="OlivierKN , WeberDJ , LeeJH , HandlerA , TudorG , MolinaPL , et al. Nontuberculous mycobacteria. II: nested-cohort study of impact on cystic fibrosis lung disease. American Journal of Respiratory and Critical Care Medicine2003;167(6):828-34. [PMID: 12433669]">Olivier 2003</a>; <a href="./references#CD010004-bbs2-0052" title="RouxAL , CatherinotE , RipollF , SoismierN , MacherasE , RavillyS , et al. Multicenter study of prevalence of nontuberculous mycobacteria in patients with cystic fibrosis in France. Journal of Clinical Microbiology2009;47(12):4124-8. [PMID: 19846643]">Roux 2009</a>). In contrast, <i>M abscessus</i> infection is more prevalent than <i>M avium</i> complex in children with CF and may lead to more deleterious clinical outcomes (<a href="./references#CD010004-bbs2-0011" title="CatherinotE ,  RouxAL ,  VibetMA ,  BellisG ,  RavillyS ,  LemonnierL , et al. Mycobacterium avium and Mycobacterium abscessus complex target distinct cystic fibrosis patient subpopulations. Journal of Cystic Fibrosis2013;12(1):74-80.">Catherinot 2013</a>; <a href="./references#CD010004-bbs2-0020" title="EstherCR , HenryMM , MolinaPL , LeighMW . Nontuberculous mycobacterial infection in young children with cystic fibrosis. Pediatric Pulmonology2005;40(1):39-44. [PMID: 15858802]">Esther 2005</a>; <a href="./references#CD010004-bbs2-0048" title="Pierre-AudigierC , FerroniA , Sermet-GaudelusI , Le BourgeoisM , OffredoC , Vu-ThienH , et al. Age-related prevalence and distribution of nontuberculous mycobacterial species among patients with cystic fibrosis. Journal of Clinical Microbiology2005;43(7):3467-70. [PMID: 16000480]">Pierre‐Audigier 2005</a>; <a href="./references#CD010004-bbs2-0050" title="QvistT , GilljamM , JönssonB , Taylor-RobinsonD , Jensen-FangelS , WangM , et al. Epidemiology of nontuberculous mycobacteria among patients with cystic fibrosis in Scandinavia. Journal of Cystic Fibrosis2015;14(1):46-52.">Qvist 2015</a>). Additional factors such as geographical location and microbiological processing methods may also impact the epidemiology of NTM in people with CF. Specific decontamination procedures in the processing of CF sputum have been recommended to improve the recovery of NTM on culture and the optimal decontamination method may be different for sputum from children compared to sputum from adults (<a href="./references#CD010004-bbs2-0051" title="RadhakrishnanDK , YauY , CoreyM , RichardsonS , ChedoreP , JamiesonF , et al. Non-tuberculous mycobacteria in children with cystic fibrosis: isolation, prevalence, and predictors. Pediatric Pulmonology2009;44(11):1100-6.">Radhakrishnan 2009</a>; <a href="./references#CD010004-bbs2-0064" title="WhittierS , HopferRL , KnowlesMR , GilliganPH . Improved recovery of mycobacteria from respiratory secretions of patients with cystic fibrosis. Journal of Clinical Microbiology1993;31(4):861-4.">Whittier 1993</a>). As NTM are environmental organisms, certain regions such as the mid‐Atlantic and southeastern United States of America are known to have high incidence of mycobacterial disease which has been linked to the high prevalence of NTM in the soil (<a href="./references#CD010004-bbs2-0010" title="BrooksRW , ParkerBC , GruftH , FalkinhamJO . Epidemiology of infection by nontuberculous mycobacteria. V. Numbers in eastern United States soils and correlation with soil characteristics. American Review of Respiratory Disease1984;130(4):630-3.">Brooks 1984</a>; <a href="./references#CD010004-bbs2-0055" title="SatyanarayanaG , HeysellSK , ScullyKW , HouptER . Mycobacterial infections in a large Virginia hospital, 2001-2009. BMC Infectious Diseases2011;11:113.">Satyanarayana 2011</a>). Outbreaks of NTM pulmonary disease have also been described in CF populations in tropical regions such as Hawaii (USA) (<a href="./references#CD010004-bbs2-0038" title="JohnstonDI , ChistyZ , GrossJE , ParkSY . Investigation of Mycobacterium abscessus outbreak among cystic fibrosis patients, Hawaii 2012. Journal of Hospital Infection2016;94(2):198-200.">Johnston 2016</a>). </p> <p>The presence of NTM species in the respiratory tract of people with CF signifies NTM infection, but NTM pulmonary disease causing clinical deterioration is more difficult to define in a progressive lung disease such as CF. The American Thoracic Society (ATS) in collaboration with the Infectious Diseases Society of America (IDSA) has outlined microbiological, clinical and radiological criteria for NTM disease (<a href="./references#CD010004-bbs2-0032" title="Griffith DE,  AksamitT ,  Brown-ElliottBA ,  CatanzaroA ,  DaleyC ,  GordinF , et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. American Journal of Respiratory and Critical Care Medicine2007;175(4):367-416. [PMID: 17277290]">Griffith 2007</a>). When examining the effects of NTM infection on the progression of CF lung disease, evidence suggests that CF cases that meet the ATS definition of NTM disease are more likely to show progression of findings on computed tomography of the chest and have a greater decline in lung function, particularly among children (<a href="./references#CD010004-bbs2-0020" title="EstherCR , HenryMM , MolinaPL , LeighMW . Nontuberculous mycobacterial infection in young children with cystic fibrosis. Pediatric Pulmonology2005;40(1):39-44. [PMID: 15858802]">Esther 2005</a>; <a href="./references#CD010004-bbs2-0032" title="Griffith DE,  AksamitT ,  Brown-ElliottBA ,  CatanzaroA ,  DaleyC ,  GordinF , et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. American Journal of Respiratory and Critical Care Medicine2007;175(4):367-416. [PMID: 17277290]">Griffith 2007</a>; <a href="./references#CD010004-bbs2-0045" title="OlivierKN , WeberDJ , LeeJH , HandlerA , TudorG , MolinaPL , et al. Nontuberculous mycobacteria. II: nested-cohort study of impact on cystic fibrosis lung disease. American Journal of Respiratory and Critical Care Medicine2003;167(6):828-34. [PMID: 12433669]">Olivier 2003</a>). In addition, infection with the <i>M abscessus</i> species, in contrast to infection with the <i>M avium</i> complex, leads to an increased rate of decline in lung function in people with CF compared to those uninfected with NTM, even after controlling for potential confounders (<a href="./references#CD010004-bbs2-0021" title="Esther CR Jr, EssermanDA , GilliganP , KerrA , NoonePG . Chronic Mycobacterium abscessus infection and lung function decline in cystic fibrosis. Journal of Cystic Fibrosis2010;9(2):117-23.">Esther 2010</a>). There is also a report of an outbreak of <i>M abscessus</i> complex among individuals with CF in a lung transplant center resulting in 60% mortality (<a href="./references#CD010004-bbs2-0005" title="Aitken ML, LimayeA , PottingerP , WhimbeyE , GossCH , TonelliMR , et al. Respiratory outbreak of Mycobacterium abscessus subspecies massiliense in a lung transplant and cystic fibrosis center. American Journal of Respiratory and Critical Care Medicine2012;185(2):231-2. [PMID: 22246710]">Aitken 2012</a>). Thus, although the distinction between simple infection and disease is often unclear, there are cases of NTM pulmonary disease in people with CF that cause worse clinical outcomes and require antimicrobial treatment. </p> </section> <section id="CD010004-sec-0010"> <h3 class="title" id="CD010004-sec-0010">Description of the intervention</h3> <p>The choice of antibiotics to treat NTM pulmonary infection depends on the species of NTM isolated and is based on data primarily from people who don't have CF. Pulmonary disease caused by <i>M avium</i> complex is usually treated with a combination of a macrolide (clarithromycin or azithromycin), rifampin or rifabutin and ethambutol (<a href="./references#CD010004-bbs2-0032" title="Griffith DE,  AksamitT ,  Brown-ElliottBA ,  CatanzaroA ,  DaleyC ,  GordinF , et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. American Journal of Respiratory and Critical Care Medicine2007;175(4):367-416. [PMID: 17277290]">Griffith 2007</a>). Of the known rapidly growing pathogenic mycobacteria, <i>M abscessus</i> is the most resistant to antimicrobials and initial treatment is frequently combination therapy with clarithromycin, amikacin and either cefoxitin or imipenem. Curative therapy of <i>M abscessus</i> lung disease is more likely to be achieved with the addition of surgical resection, but this is unlikely to be possible in a diffuse disease such as CF (<a href="./references#CD010004-bbs2-0030" title="Griffith DE,  GirardWM ,  Wallace RJ Jr. Clinical features of pulmonary disease caused by rapidly growing mycobacteria. An analysis of 154 patients. American Review of Respiratory Disease1993;147(5):1271-8. [PMID: 8484642]">Griffith 1993</a>). Alternative therapies may be considered if in vitro susceptibility testing demonstrates resistance to these initial agents. However, in vitro susceptibility results do not always predict in vivo clinical response to therapeutic agents as clinical response depends partly on local and host defense systems (<a href="./references#CD010004-bbs2-0040" title="Maniu CV,  HellingerWC ,  ChuSY ,  PalmerR ,  Alvarez-ElcoroS . Failure of treatment for chronic Mycobacterium abscessus meningitis despite adequate clarithromycin levels in cerebrospinal fluid. Clinical Infectious Diseases2001;33(5):745-8.">Maniu 2001</a>). For <i>M abscessus</i> species, there is no correlation between in vitro susceptibility results to any agent and clinical response to the treatment of pulmonary disease by these agents. Nonetheless, alternative classes of antibiotics can be considered if there is a lack of clinical response, concerns for drug toxicity or in vitro resistance noted with initial antimicrobial agents. Based on multiple studies of in vitro antimicrobial susceptibility testing of <i>M abscessus</i> isolates, alternative antibiotics include: ciprofloxacin (susceptibility range 3% to 82%); gatifloxacin (7% to 91% susceptible); moxifloxacin (8% to 88% susceptible); linezolid (32% susceptible); and tigecycline (100% susceptible) (<a href="./references#CD010004-bbs2-0027" title="GayathriR , ThereseKL , DeepaP , MangaiS , MadhavanHN . Antibiotic susceptibility pattern of rapidly growing mycobacteria. Journal of Postgraduate Medicine2010;56(2):76-8. [PMID: 20622384]">Gayathri 2010</a>; <a href="./references#CD010004-bbs2-0041" title="MiyasakaT ,  KunishimaH ,  KomatsuM ,  TamaiK ,  MitsutakeK ,  KanemitsuK , et al. In vitro efficacy of imipenem in combination with six antimicrobial agents against Mycobacterium abscessus. International Journal of Antimicrobial Agents2007;30(3):255-8. [PMID: 17616451]">Miyasaka 2007</a>; <a href="./references#CD010004-bbs2-0046" title="ParkS ,  KimS ,  ParkEM ,  KimH ,  KwonOJ ,  ChangCL , et al. In vitro antimicrobial susceptibility of Mycobacterium abscessus in Korea. Journal of Korean Medical Science2008;23(1):49-52. [PMID: 18303198]">Park 2008</a>; <a href="./references#CD010004-bbs2-0062" title="Wallace RJ Jr, Brown-ElliottBA , CristCJ , MannL , WilsonRW . Comparison of the in vitro activity of the glycylcycline tigecycline (formerly GAR-936) with those of tetracycline, minocycline, and doxycycline against isolates of nontuberculous mycobacteria. Antimicrobial Agents and Chemotherapy2002;46(10):3164-7. [PMID: 12234839]">Wallace 2002</a>; <a href="./references#CD010004-bbs2-0065" title="Yang SC, HsuehPR , LaiHC , TengLJ , HuangLM , ChenJM , et al. High prevalence of antimicrobial resistance in rapidly growing mycobacteria in Taiwan. Antimicrobial Agents and Chemotherapy2003;47(6):1958-62. [PMID: 12760874]">Yang 2003</a>). It is important to note that <i>M abscessus</i> isolates may be intrinsically resistant to macrolides due to the expression of a novel <i>erm</i> gene (<a href="./references#CD010004-bbs2-0042" title="NashKA , Brown-ElliottBA , Wallace RJ Jr. A novel gene, erm (41), confers inducible macrolide resistance to clinical isolates of Mycobacterium abscessus but is absent from Mycobacterium chelonae. Antimicrobial Agents and Chemotherapy2009;53(4):1367-76.">Nash 2009</a>). There is some evidence to suggest that clarithromycin induces greater <i>erm</i> (41) expression and thus higher macrolide resistance than azithromycin in <i>M abscessus</i> infection; both macrolides appear to be equally effective against <i>M massiliense</i> species (<a href="./references#CD010004-bbs2-0016" title="Choi GE,  ShinSJ ,  WonCJ ,  MinKN ,  OhT ,  HahnMY , et al. Macrolide treatment for Mycobacterium abscessus and M. massiliense infection and inducible resistance. American Journal of Respiratory and Critical Care Medicine 2012 Aug 9 [Epub ahead of print].">Choi 2012</a>; <a href="./references#CD010004-bbs2-0053" title="RouxAL , CatherinotE , SoismierN , HeymB , BellisG , LemonnierL , et al. Comparing Mycobacterium massiliense and Mycobacterium abscessus lung infections in cystic fibrosis patients. Journal of Cystic Fibrosis2015;14(1):63-9.">Roux 2015</a>). In addition, people with CF may have been previously treated with antibiotics such as ciprofloxacin or azithromycin (for <i>P aeruginosa</i> ) or linezolid (for methicillin‐resistant <i>S aureus</i> (MRSA)) (<a href="./references#CD010004-bbs2-0063" title="WatersV . New treatments for emerging cystic fibrosis pathogens other than Pseudomonas. Current Pharmaceutical Design2012;18(5):696-725.">Waters 2012a</a>) and their NTM species may thus already be resistant in vitro to these agents. </p> </section> <section id="CD010004-sec-0011"> <h3 class="title" id="CD010004-sec-0011">How the intervention might work</h3> <p>There are several case reports of people with CF with NTM infection and severe lung disease clinically responding to antimicrobial therapy which targets the specific NTM species leading to eradication of the organism (<a href="./references#CD010004-bbs2-0024" title="FaurouxB , DelaisiB , ClementA , SaizouC , MoissenetD , Truffot-PernotC , et al. Mycobacterial lung disease in cystic fibrosis: a prospective study. Pediatric Infectious Disease Journal1997;16(4):354-8. [PMID: 9109135]">Fauroux 1997</a>). Antibiotic treatment of NTM pulmonary infections thus has the potential to improve lung function, reduce the frequency of pulmonary exacerbations and eliminate the bacteria from the lung in people with CF. However, there are no data on the effectiveness of early antibiotic therapy to eradicate NTM or chronic antimicrobial suppressive treatment of NTM to prevent lung function decline in CF patients. Early antibiotic therapy to eradicate NTM consists of initiation of antimicrobial treatment on first isolation of an organism in order to eliminate it from the CF lung. Chronic antimicrobial suppressive treatment refers to prolonged antimicrobial therapy to reduce the bacterial burden of the organism in the lung. Furthermore, it is not clear what is the optimal choice of antibiotics or route of antibiotic administration (oral, intravenous or inhaled) with which to treat these patients. </p> </section> <section id="CD010004-sec-0012"> <h3 class="title" id="CD010004-sec-0012">Why it is important to do this review</h3> <p>This review is important because NTM pulmonary infections affect a significant proportion of people with CF worldwide. Data on the treatment and management of these infections is currently extrapolated from a non‐CF population and its applicability to CF lung disease is unclear. It is thus necessary to determine whether there are antibiotic treatments for NTM lung infections which result in improved clinical or microbiological outcomes in people with CF. </p> <p>This is an update of a previously published version of the review (<a href="./references#CD010004-bbs2-0066" title="WatersV , RatjenF . Antibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosis. Cochrane Database of Systematic Reviews2012, Issue 7. [DOI: 10.1002/14651858.CD010004]">Waters 2012b</a>; <a href="./references#CD010004-bbs2-0067" title="WatersV , RatjenF . Antibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosis. Cochrane Database of Systematic Reviews2012, Issue 12. [DOI: 10.1002/14651858.CD010004.pub2]">Waters 2012c</a>; <a href="./references#CD010004-bbs2-0068" title="WatersV , RatjenF . Antibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosis. Cochrane Database of Systematic Reviews2014, Issue 12. [DOI: 10.1002/14651858.CD010004.pub3]">Waters 2014</a>; <a href="./references#CD010004-bbs2-0069" title="WatersV , RatjenF . Antibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosis. Cochrane Database of Systematic Reviews2016, Issue 12. [DOI: 10.1002/14651858.CD010004.pub4]">Waters 2016</a>). </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD010004-sec-0013" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD010004-sec-0013"></div> <p>To compare antibiotic treatment to no antibiotic treatment, or to compare different combinations of antibiotic treatment, for NTM lung infections in people with CF. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD010004-sec-0014" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD010004-sec-0014"></div> <section id="CD010004-sec-0015"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD010004-sec-0016"> <h4 class="title">Types of studies</h4> <p>Randomized controlled trials.</p> </section> <section id="CD010004-sec-0017"> <h4 class="title">Types of participants</h4> <p>Adults and children (ages 0 to 18 years) diagnosed with CF (with all levels of disease severity), confirmed with sweat test or genetic testing, or both, who have NTM pulmonary infection (defined as at least two respiratory specimens positive by culture for NTM ‐ post hoc change) will be included. Individuals with a respiratory tract specimen that is positive on stain for acid‐fast bacilli (AFB) but culture negative for NTM will not be included. Respiratory tract specimens will include sputum, lung biopsy or bronchoalveolar lavage specimens. Individuals with CF who have received a lung transplant will be excluded. </p> </section> <section id="CD010004-sec-0018"> <h4 class="title">Types of interventions</h4> <p>The intervention was antibiotics to treat NTM pulmonary infections. We planned to compare NTM antibiotics to no antibiotic treatment as well as compare different NTM antibiotic regimens. Antibiotics included single or multiple antibiotics, oral, inhaled or intravenous antibiotics. Surgical interventions were excluded. </p> </section> <section id="CD010004-sec-0019"> <h4 class="title">Types of outcome measures</h4> <section id="CD010004-sec-0020"> <h5 class="title">Primary outcomes</h5> <p> <ol id="CD010004-list-0001"> <li> <p>Lung function</p> <ol id="CD010004-list-0002"> <li> <p>forced expiratory volume in one second (FEV<sub>1</sub>) (absolute values L or per cent (%) predicted or both) </p> </li> <li> <p>forced vital capacity (FVC) (absolute values L or % predicted or both)</p> </li> <li> <p>mid‐expiratory flow (FEF<sub>25-75</sub>) (absolute values L or % predicted or both) </p> </li> </ol> </li> <li> <p>Pulmonary exacerbations, defined as an increase in respiratory symptoms requiring intravenous antibiotic therapy (<a href="./references#CD010004-bbs2-0026" title="FuchsHJ ,  BorowitzDS ,  ChristiansenDH ,  MorrisEM ,  NashML ,  RamseyBW , et al. Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group. New England Journal of Medicine1994;331(10):637-42. [PMID: 7503821]">Fuchs 1994</a>) (if pulmonary exacerbations are not defined in the trial, data from that trial relating to pulmonary exacerbations will not be reported in this review) </p> <ol id="CD010004-list-0003"> <li> <p>number of pulmonary exacerbations</p> </li> <li> <p>time between pulmonary exacerbations</p> </li> <li> <p>time to subsequent exacerbation</p> </li> </ol> </li> <li> <p>Adverse events (proportion of participants who had to withdraw or changed therapy)</p> <ol id="CD010004-list-0004"> <li> <p>mild: transient event, no treatment change, e.g. rash, nausea, diarrhoea</p> </li> <li> <p>moderate: treatment discontinued, e.g. nephrotoxicity, ototoxicity, hepatitis, visual impairment </p> </li> <li> <p>severe: causing hospitalization or death</p> </li> </ol> </li> </ol> </p> </section> <section id="CD010004-sec-0021"> <h5 class="title">Secondary outcomes</h5> <p> <ol id="CD010004-list-0005"> <li> <p>Quality of life (QoL) (as measured by a validated QoL score, i.e. CFQoL (<a href="./references#CD010004-bbs2-0028" title="GeeL , AbbottJ , ConwayS , EtheringtonC , WebbA . Development of a disease specific health related quality of life measure for adults and adolescents with cystic fibrosis. Thorax2000;55(11):946-54. [PMID: 11050265]">Gee 2000</a>), CFQ‐R (<a href="./references#CD010004-bbs2-0049" title="QuittnerAL , ModiAC , WainwrightC , OttoK , KiriharaJ , MontgomeryAB . Determination of the minimal clinically important difference scores for the Cystic Fibrosis Questionnaire-Revised respiratory symptom scale in two populations of patients with cystic fibrosis and chronic Pseudomonas aeruginosa airway infection. Chest2009;135(6):1610-8. [PMID: 19447923]">Quittner 2009</a>)) </p> </li> <li> <p>Mortality</p> </li> <li> <p>Nutritional parameters</p> <ol id="CD010004-list-0006"> <li> <p>weight</p> </li> <li> <p>height</p> </li> <li> <p>body mass index (BMI)</p> </li> </ol> </li> <li> <p>Hospitalizations</p> <ol id="CD010004-list-0007"> <li> <p>number of hospitalizations</p> </li> <li> <p>duration (days)</p> </li> </ol> </li> <li> <p>Use of oral antibiotics</p> </li> <li> <p>Quantitative sputum mycobacterial culture (decrease in quantity or eradication) (post hoc change) </p> </li> </ol> </p> </section> </section> </section> <section id="CD010004-sec-0022"> <h3 class="title">Search methods for identification of studies</h3> <p>Trials are eligible irrespective of publication status or language.</p> <section id="CD010004-sec-0023"> <h4 class="title">Electronic searches</h4> <p>We attempted to identify relevant trials from the Group's Cystic Fibrosis Trials Register using the terms: nontuberculous mycobacteria [NTM] AND antibiotics. </p> <p>The Cystic Fibrosis Trials Register is compiled from electronic searches of the Cochrane Central Register of Controlled Trials (CENTRAL) (updated each new issue of the <i>Cochrane Library</i> ), weekly searches of MEDLINE, a search of Embase to 1995 and the prospective handsearching of two journals ‐ <i>Pediatric Pulmonology</i> and the <i>Journal of Cystic Fibrosis</i>. Unpublished work is identified by searching the abstract books of three major cystic fibrosis conferences: the International Cystic Fibrosis Conference; the European Cystic Fibrosis Conference and the North American Cystic Fibrosis Conference. For full details of all searching activities for the register, please see the relevant sections of the Cystic Fibrosis and Genetic Disorders Group <a href="http://cfgd.cochrane.org/our-specialised-trials-registers" target="_blank">website</a>. </p> <p>Date of last search of the CF Trials Register: 24 February 2020.</p> <p>We also checked the National Institutes of Health (NIH) sponsored website <a href="http://www.clinicaltrials.gov" target="_blank">www.clinicaltrials.gov</a>and the WHO International Clinical Trials Registry (<a href="http://apps.who.int/trialsearch/" target="_blank">apps.who.int/trialsearch/</a>) for any ongoing trials (search terms: nontuberculous mycobacteria, atypical mycobacteria, cystic fibrosis) and contacted the authors or manufacturers for potential interim results. </p> <p>Date of last search of online trials registries: 16 April 2020.</p> </section> <section id="CD010004-sec-0024"> <h4 class="title">Searching other resources</h4> <p>We planned to check the reference lists of all trials identified for any further relevant trials. </p> </section> </section> <section id="CD010004-sec-0025"> <h3 class="title" id="CD010004-sec-0025">Data collection and analysis</h3> <p>One completed trial was identified by the searches, but data specific to individuals with CF could not be obtained from the pharmaceutical company so we were unable to carry out the planned analysis as detailed below. However, if in future updates of this review we are able to obtain data from any trials, we plan the following analysis. </p> <section id="CD010004-sec-0026"> <h4 class="title">Selection of studies</h4> <p>The two authors (VW, FR) will independently apply the inclusion criteria to all potential trials. The authors will not be blinded to the trials. If a disagreement occurs, it will be resolved by discussion with a third person (Nikki Jahnke (NJ)). </p> </section> <section id="CD010004-sec-0027"> <h4 class="title">Data extraction and management</h4> <p>Using a data collection form, two authors (VW, FR) will independently obtain data from published reports or from trial investigators. If a disagreement occurs, the authors will resolve this by discussion with a third person (NJ). In addition to information about trial references and authors and verification of trial eligibility, the data collection form includes information about the methods of the trial (e.g. trial duration, type of trial, blinding, number of dropouts and potential confounders). When possible, the authors will extract data on sequence generation and allocation concealment. The authors will report characteristics of the trial participants including age, sex and setting of the trial on the form. Furthermore, they will also describe the intervention with regards to type of antibiotic, route of delivery, doses and length of treatment. The authors will initially analyze data from trials with different types of antibiotic, routes of delivery, doses and lengths of treatment all together and then separately in subgroup analyses (e.g. data from trials comparing oral antibiotic NTM treatments ‐ see below). The authors will collect data for all randomized participants and attempt to collect the following data: the mean change (before and after antibiotic therapy) in FEV<sub>1</sub> and FVC, FEF<sub>25-75</sub>; the mean hospital length of stay; the time to subsequent pulmonary exacerbation; the number of adverse events; the mean QoL score after antibiotic therapy; the number of mortalities and change in weight (before and after antibiotic therapy) (see <a href="#CD010004-sec-0019">Types of outcome measures</a> for a complete list of outcomes). For each mean value, the authors will also obtain the standard deviation (SD) (variation from the average). For time to subsequent exacerbation, they will try to obtain log‐rank estimates and Cox model estimates. </p> <p>Given that NTM pulmonary infections are generally treated with more long‐term antibiotics, the authors plan to measure outcomes at the following time points: one month and up to six months; six months and up to one year; and one year or longer interval. They will measure the outcome 'Time to subsequent pulmonary exacerbation' in monthly intervals after these time points. The authors will also consider outcomes measured at other time points. </p> </section> <section id="CD010004-sec-0028"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>The authors will assess the included trials for the following types of bias: selection bias (bias in choosing study participants); performance bias (bias in the care of study participants); attrition bias (bias in how participant loss to follow up is handled); detection bias (biased assessment of outcome); and reporting bias (bias in the reporting of study outcomes) (<a href="./references#CD010004-bbs2-0035" title="HigginsJPT , Altman DG (editors). Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.">Higgins 2011b</a>) using the following strategies as outlined below. </p> <section id="CD010004-sec-0029"> <h5 class="title">Assessment of generation of allocation sequences</h5> <p>They will assess each trial as to the generation of allocation sequences:</p> <p> <ol id="CD010004-list-0008"> <li> <p>low risk of bias: if allocation sequence is suitable to prevent selection bias (i.e. random numbers table, drawing envelopes, tossing a coin, throwing dice etc); </p> </li> <li> <p>high risk of bias: if allocation sequence could be related to prognosis and thus introduce selection bias (i.e. assigning participants based on case record number, date of birth, date of admission etc); </p> </li> <li> <p>uncertain risk of bias: if the trial is described as randomised but the method used to generate the allocation sequence is not stated. </p> </li> </ol> </p> </section> <section id="CD010004-sec-0030"> <h5 class="title">Assessment of concealment of allocation sequences</h5> <p>They will also assess the method used to conceal the allocation sequences in each trial: </p> <p> <ol id="CD010004-list-0009"> <li> <p>low risk of bias: if participants and investigators cannot predict which group the participant will be assigned to (i.e. coded drug containers, central randomisation, numbered, sealed, opaque envelopes etc); </p> </li> <li> <p>high risk of bias: if participants and investigators can predict which group the participant will be assigned to and thus introduce selection bias (i.e. open allocation schedule, non‐opaque envelopes etc); </p> </li> <li> <p>uncertain risk of bias: if the method of concealing the allocation sequence is not described. </p> </li> </ol> </p> </section> <section id="CD010004-sec-0031"> <h5 class="title">Assessment of blinding</h5> <p>In order to determine the potential for performance and detection bias, the authors will assess each trial with respect to the degree of blinding: </p> <p> <ol id="CD010004-list-0010"> <li> <p>the participant is blinded to participant assignment;</p> </li> <li> <p>the care provider is blinded to participant assignment;</p> </li> <li> <p>the investigator measuring study outcomes is blinded to participant assignment.</p> </li> </ol> </p> <p>There will be a high risk of bias if there is no blinding with respect to one or more of the above categories. There will be a low risk of bias if the trial is blinded to all three. There will be an uncertain risk of bias if the trial does not specify the degree of blinding in each of the three categories. </p> </section> <section id="CD010004-sec-0032"> <h5 class="title">Incomplete outcome data</h5> <p>To assess for the possibility of attrition bias, the authors will examine each trial with respect to: </p> <p> <ol id="CD010004-list-0011"> <li> <p>whether or not it was stated how many participants were lost to follow‐up and why they were lost to follow‐up; </p> </li> <li> <p>whether or not an intention‐to‐treat analysis was used (i.e. inclusion in the final analysis of all randomized participants into a trial in the groups to which they were randomized irrespective of what happened subsequently). </p> </li> </ol> </p> <p>There will be a high risk of bias if an intention‐to‐treat analysis was not used. There will be a low risk of bias if the number and reason for loss of follow‐up is specified and if an intention‐to‐treat analysis was used. There will be an uncertain risk of bias if the trial does not specify the above outlined information. </p> </section> <section id="CD010004-sec-0033"> <h5 class="title">Assessment of selective reporting</h5> <p>The authors will review the included trials for selective reporting (<a href="./references#CD010004-bbs2-0035" title="HigginsJPT , Altman DG (editors). Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.">Higgins 2011b</a>). They will compare the original trial protocols with the published paper(s) to ensure all planned outcomes are reported. If the original trial protocols are not available, they will review the 'Methods' and 'Results' sections and use their discretion to determine if selective reporting has occurred. </p> </section> <section id="CD010004-sec-0034"> <h5 class="title">Assessment of other potential sources of bias</h5> <p>The authors will also review the included trials for other potential sources of bias that will threaten the validity of the trial. These will include: early cessation of the trial; if the interim results affect the trial conduct; deviation from the trial protocol; inappropriate administration of a co‐intervention; contamination; the use of an insensitive instrument to measure outcomes; selective reporting of subgroups; fraud; inappropriate influence of funding agencies and industry sponsorship; null bias due to the interventions being poorly delivered; or the existence of a pre‐randomization of an intervention that could affect the effects of the randomized intervention (<a href="./references#CD010004-bbs2-0034" title="HigginsJPT , Deeks JJ (editors). Chapter 7: Selecting studies and collecting data. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.">Higgins 2011a</a>). </p> </section> <section id="CD010004-sec-0035"> <h5 class="title">Incorporating assessments of study validity in reviews</h5> <p>The authors plan to weigh trials according to their assessed validity by using the inverse of the variance for the estimated measure of effect. If they consider there was a high risk of bias, they will investigate the effects of this with a sensitivity analysis (see below). </p> </section> </section> <section id="CD010004-sec-0036"> <h4 class="title">Measures of treatment effect</h4> <p>For dichotomous data, the authors will gather information on participants randomized to each treatment group (antibiotics versus no antibiotics or one antibiotic regimen versus another regimen), based on an intention‐to‐treat analysis, and the number of events. They plan to include interim results from individual randomized participants with CF from ongoing studies in the analysis. They will define time points for each trial outcome according to when it was measured (one to six months, six months up to one year, one year or over). They will analyze trial outcomes separately according to these time points. The authors plan to pool the treatment effect across studies to determine a relative risk (RR) and its 95% confidence intervals (CIs) for each outcome. </p> <p>For continuous data, the authors will calculate the difference between the mean (average) values (MD) of treatment effect for each group, the number in each group and the standard deviation (SD). As a summary statistic across trials, they will use the MD if the same scale is used, or the standardised mean difference (SMD) if different scales are used (e.g. QoL measurements) both with 95% CIs. For time‐to‐event data, most trials use Kaplan‐Meier survival analysis. The authors will thus collect log‐rank estimates and Cox model estimates to subsequently summarize the time‐to‐event data as a hazard ratio (HR) with 95% CIs (<a href="./references#CD010004-bbs2-0017" title="DeeksJ , HigginsJ , AltmanD . Chapter 9 Analysing data and undertaking meta-analysis. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.">Deeks 2011</a>; <a href="./references#CD010004-bbs2-0047" title="ParmarMK , TorriV , StewartL . Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Statistics in Medicine1998;17(24):2815-34. [PMID: 9921604]">Parmar 1998</a>). </p> </section> <section id="CD010004-sec-0037"> <h4 class="title">Unit of analysis issues</h4> <p>The authors will include data from cluster‐randomized trials if the information is available. For cluster­randomized trials, they will calculate the intra‐cluster correlation coefficient (ICC) according to Donner (<a href="./references#CD010004-bbs2-0018" title="DonnerA , PiaggioG , VillarJ . Statistical methods for the meta-analysis of cluster randomized trials. Statistical Methods in Medical Research2001;10(5):325-38. [PMID: 11697225]">Donner 2001</a>). They will also include data from cross‐over trials if the information is available. Continuous data from cross‐over trials will be analyzed using one of three approaches: treat the study as a parallel trial and pool the interventional periods and compare these to the pooled placebo periods; include data from the first period only and approximate a paired analysis; impute missing SDs (<a href="./references#CD010004-bbs2-0036" title="HigginsJPT , DeeksJJ , Altman DG on behalf of the CSMG . Chapter 16: Special topics in statistics. In: Higgins JPT, Green S (editors). Cochrane Handbook of Systematic Reviews of Interventions. Version 5.1 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.">Higgins 2011c</a>). Cross‐over trials with dichotomous outcomes require more complicated analysis methods and for this the authors will consult with a statistician (<a href="./references#CD010004-bbs2-0019" title="ElbourneDR , AltmanDG , HigginsJPT , CurtinF , WorthingtonHV , VailA . Meta-analyses involving cross-over trials: methodological issues. International Journal of Epidemiology2002;31(1):140-9. [PMID: 11914310]">Elbourne 2002</a>). </p> </section> <section id="CD010004-sec-0038"> <h4 class="title">Dealing with missing data</h4> <p>Data are often missing for participants who are lost to follow‐up. In these situations, the authors will perform an available‐case analysis (analyzing data for every participant for whom the outcome is obtained). They will report the percentages of participants from whom no outcome data were obtained on the data collection form. They will include data on only those whose results are known, using as a denominator the total number of people who completed the trial for the particular outcome in question. The authors will consider variation in the degree of missing data across trials as a potential source of heterogeneity. </p> </section> <section id="CD010004-sec-0039"> <h4 class="title">Assessment of heterogeneity</h4> <p>In performing a meta‐analysis, the authors will measure the variability of results between trials (heterogeneity) using the I² method (with CIs) outlined by Higgins (<a href="./references#CD010004-bbs2-0033" title="HigginsJPT , ThompsonSG , DeeksJJ , AltmanDG . Measuring inconsistency in meta-analyses. BMJ2003;327(7414):557-60. [PMID: 12958120]">Higgins 2003</a>). The I² statistic describes the percentage of total variation across trials that is due to heterogeneity rather than chance. It is calculated using Cochran's heterogeneity statistic and the degrees of freedom. The I² statistic can range from 0% to 100%. A value of 0% indicates no observed heterogeneity and larger values show increasing heterogeneity. The authors will consider a value greater than 50% as substantial heterogeneity. They will also visually inspect the forest plot to assess the heterogeneity between trials.  </p> </section> <section id="CD010004-sec-0040"> <h4 class="title">Assessment of reporting biases</h4> <p>To investigate whether the review is subject to publication bias, and if they are able to include sufficient trials (at least 10), the authors will construct a funnel plot. In the absence of bias, the plot should resemble a symmetrical inverted funnel (<a href="./references#CD010004-bbs2-0058" title="SterneJ , EggerM , MoherD . Chapter 10: Addressing reporting biases. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.">Sterne 2011</a>). If there is asymmetry, the authors will consider publication bias and other reasons (such as location biases, true heterogeneity, poor methodological quality of smaller trials etc) as a potential cause. </p> </section> <section id="CD010004-sec-0041"> <h4 class="title">Data synthesis</h4> <p>If the authors consider that the trials are clinically similar enough to combine (e.g. studies comparing different antibiotic combinations to treat pulmonary exacerbations in participants with NTM infection), they will investigate statistical heterogeneity as outlined below. If there is no substantial heterogeneity, they will calculate the pooled effect estimates using a fixed‐effect model. If they identify substantial heterogeneity (I<sup>2</sup> statistic is greater than 50%), they will perform a random‐effects meta‐analysis to incorporate heterogeneity between trials. </p> </section> <section id="CD010004-sec-0042"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>If the authors find substantial heterogeneity (I² statistic is greater than 50%) (<a href="./references#CD010004-bbs2-0033" title="HigginsJPT , ThompsonSG , DeeksJJ , AltmanDG . Measuring inconsistency in meta-analyses. BMJ2003;327(7414):557-60. [PMID: 12958120]">Higgins 2003</a>), they will explore the potential causes of this (i.e. different types of antimicrobial treatment such as oral, inhaled or intravenous; different participant populations; different species of NTM etc) and if possible (if at least five trials are included for that outcome) conduct subgroup analyses of the trials. For example, trial results may vary if different types of antibiotic treatment are used (e.g. oral, inhaled or intravenous) for the treatment of pulmonary infection, or different treatment durations (e.g. six months versus one year). There may also be differences depending on whether antibiotics are used to treat a first‐time infection (eradication) versus an established, chronic infection (when more than 50% of cultures are positive in the previous 12 months). Finally, there may be differing effects of antibiotic treatment of NTM pulmonary infection depending on the type of NTM species isolated (e.g. antimicrobial treatment of <i>M abscessus</i> pulmonary infections may show more of a clinical benefit than treatment of <i>M avium</i> complex infections). </p> </section> <section id="CD010004-sec-0043"> <h4 class="title">Sensitivity analysis</h4> <p>If the authors are able to include at least 10 trials in the review, they will perform a sensitivity analysis to determine whether the conclusions are robust to decisions made during the review process such as inclusion or exclusion of particular studies from a meta‐analysis, imputing missing data or choice of a method for analysis<i>.</i> They will investigate whether changing which studies are included, based on their assessment of the risk of bias (initially including all trials and then excluding any with a high risk of bias) or changing our chosen statistical model (i.e. random‐effects model compared to a fixed‐effect model) changes the results of the review. If the sensitivity analyses do not significantly change the results presented in the review, it strengthens the confidence that can be placed in these results. The authors will present the results in an influence plot, as appropriate. </p> </section> <section id="CD010004-sec-0044"> <h4 class="title">Summary of findings tables</h4> <p>We will prepare summary of findings tables for each comparison included in the review. We will list population, setting, intervention and comparison and report an illustrative risk for the experimental and control intervention (<a href="./references#CD010004-bbs2-0057" title="SchünemannHJ , OxmanAD , HigginsJPT , VistGE , GlasziouP , Guyatt GH on behalf of the CA and RMG and the CSMG . Chapter 11: Presenting results and ‘Summary of findings’ tables. In: Higgins JPT, Green S editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.">Schünemann 2011</a>). We will grade of overall quality of the body of evidence as high, moderate, low or very low using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) (<a href="./references#CD010004-bbs2-0056" title="SchünemannHJ , FretheimA , OxmanAD . Improving the use of research evidence in guideline development: 9. Grading evidence and recommendations. Health Research Policy and Systems2006;4:21. [DOI: 10.1186/1478-4505-4-21]">Schünemann 2006</a>). We will base our judgements on the risk of bias within the trials, their relevance to our population of interest (indirectness), unexplained heterogeneity or inconsistency, imprecision of the results or high risk of publication bias. We will downgrade the evidence once if the risk was serious and twice if the risk was deemed to be very serious and will describe the rationale for each judgement in footnotes to each table. </p> <p>For each comparison we will report the following outcomes:</p> <p> <ul id="CD010004-list-0012"> <li> <p>number of pulmonary exacerbations;</p> </li> <li> <p>change from baseline in FEV<sub>1</sub>; </p> </li> <li> <p>sputum mycobacterial culture conversion;</p> </li> <li> <p>adverse events;</p> </li> <li> <p>mortality;</p> </li> <li> <p>number of hospitalizations;</p> </li> <li> <p>BMI.</p> </li> </ul> </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD010004-sec-0045" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD010004-sec-0045"></div> <section id="CD010004-sec-0046"> <h3 class="title">Description of studies</h3> <p>Please see the tables for further details (<a href="./references#CD010004-sec-0069" title="">Characteristics of excluded studies</a>; <a href="./references#CD010004-sec-0070" title="">Characteristics of studies awaiting classification</a>). </p> <section id="CD010004-sec-0047"> <h4 class="title">Results of the search</h4> <p>To date we have identified two published randomized controlled trials (<a href="./references#CD010004-bbs2-0002" title="MartinianoS , WagnerB , BrennanL , WempeM , AndersonP , NickJ , et al. Pharmacokinetics of oral mac antibiotics in cystic fibrosis. American Journal of Respiratory and Critical Care Medicine2017;195:A4842. [CENTRAL: CN-01476112] [CFGD REGISTER: PI320a] [EMBASE: 617708689]MartinianoS , WagnerB , BrennanL , WempeM , AndersonP , NickJ , et al. Pharmacokinetics of oral mac antibiotics in cystic fibrosis. Journal of Cystic Fibrosis2017;16 Suppl 1:S52. [ABSTRACT NO.: EPS7.2] [CENTRAL: CN-01476112] [CFGD REGISTER: PI320b] [EMBASE: 617708689]">Martiniano 2017</a>; <a href="./references#CD010004-bbs2-0003" title="BillerJA , EagleG , McGinnisJP , MicioniL , DaleyCL , WinthropKL , et al. Efficacy of liposomal amikacin for inhalation (LAI) in achieving nontuberculous mycobacteria (NTM) culture negativity in patients whose lung infection is refractory to guideline-based therapy. American Journal of Respiratory and Critical Care Medicine2015;191 Suppl:no pagination. [CENTRAL: 1136597] [CFGD REGISTER: PI281e] [EMBASE: 72054175]NCT01315236. Arikace® for Nontuberculous Mycobacteria. www.clinicaltrials.gov/ct2/show/NCT01315236?term=arikace&amp;rank=4 (accessed 01 October 2012). [CLINICALTRIALS.GOV IDENTIFIER: NCT01315236] OlivierKN , EagleG , McGinnis IIJP , MicioniL , DaleyCL , WinthropKL , et al. Randomized, double-blind, placebo-controlled, open-label study of liposomal amikacin for inhalation (LAI) in patients with recalcitrant nontuberculous mycobacterial lung disease (NTM-LD) [abstract]. Pediatric Pulmonology2014;49 Suppl 38:321, Abstract no: 293. [CENTRAL: 1012528] [CFGD REGISTER: PI281a] OlivierKN , EagleG , McGinnisJP , MicioniL , DaleyCL , WinthropKL , et al. Randomized, double-blind (DB), placebo-controlled study and open-label (OL) extension of liposomal amikacin for inhalation (LAI) in patients with refractory nontuberculous mycobacterial (NTM) lung disease (LD) [abstract]. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society2015;14 Suppl 1:S3, Abstract no: WS02.3. [CENTRAL: 1099086] [CFGD REGISTER: PI281b] OlivierKN , GriffithDE , EagleG , McGinnisJP , MicioniL , LiuK , et al. Randomized trial of liposomal amikacin for inhalation in nontuberculous mycobacterial lung disease. American Journal of Respiratory and Critical Care Medicine2017;195(6):814-23. [CFGD REGISTER: PI281g] OlivierKN , GuptaR , DaleyCL , WinthropKL , RuossS , Addrizzo-HarrisDJ , et al. A randomized, double-blind, placebo-controlled study of liposomal Amikacin for inhalation (Arikace) in patients with recalcitrant nontuberculous mycobacterial lung disease. American Journal of Respiratory and Critical Care Medicine2014;189:C27. [ABSTRACT NO.: A4126] [CFGD REGISTER: PI281f] RuossSJ , EagleG , McGinnisJP , MicioniL , DaleyCL , WinthropKL , et al. Analysis of functional exercise capacity (via the six-minute walk test [6MWT]) and culture negativity in patients with nontuberculous mycobacteria (NTM) lung infection refractory to guideline-based therapy treated with liposomal amikacin for inhalation (LAI). American Journal of Respiratory and Critical Care Medicine2015;191 Suppl:no pagination. [CENTRAL: 1136596] [CFGD REGISTER: PI281d] [EMBASE: 72054176]WinthropKL , EagleG , McGinnisJP , MicioniL , DaleyCL , RuossSJ , et al. Subgroup analyses of baseline demographics and efficacy in patients with refractory nontuberculous mycobacteria (NTM) lung infection treated with liposomal amikacin for inhalation (LAI). American Journal of Respiratory and Critical Care Medicine2015;191 Suppl:no pagination. [CENTRAL: 1136598] [CFGD REGISTER: PI281c] [EMBASE: 72054174]">Olivier 2017</a>). We also identified one ongoing study (<a href="./references#CD010004-bbs2-0001" title="NCT04294043. IV gallium study for patients with cystic fibrosis who have NTM (ABATE Study) (ABATE) [A Phase 1b, Multi-center Study of Intravenous (IV) Gallium Nitrate in Patients With Cystic Fibrosis (CF) Who Are Colonized With Nontuberculous Mycobacteria (NTM) (The ABATE Study)]. www.clinicaltrials.gov/ct2/show/NCT04294043 (first posted 03 March 2020). ">ABATE</a>). We have excluded one published trial and one ongoing study (<a href="./references#CD010004-bbs2-0001" title="NCT04294043. IV gallium study for patients with cystic fibrosis who have NTM (ABATE Study) (ABATE) [A Phase 1b, Multi-center Study of Intravenous (IV) Gallium Nitrate in Patients With Cystic Fibrosis (CF) Who Are Colonized With Nontuberculous Mycobacteria (NTM) (The ABATE Study)]. www.clinicaltrials.gov/ct2/show/NCT04294043 (first posted 03 March 2020). ">ABATE</a>; <a href="./references#CD010004-bbs2-0002" title="MartinianoS , WagnerB , BrennanL , WempeM , AndersonP , NickJ , et al. Pharmacokinetics of oral mac antibiotics in cystic fibrosis. American Journal of Respiratory and Critical Care Medicine2017;195:A4842. [CENTRAL: CN-01476112] [CFGD REGISTER: PI320a] [EMBASE: 617708689]MartinianoS , WagnerB , BrennanL , WempeM , AndersonP , NickJ , et al. Pharmacokinetics of oral mac antibiotics in cystic fibrosis. Journal of Cystic Fibrosis2017;16 Suppl 1:S52. [ABSTRACT NO.: EPS7.2] [CENTRAL: CN-01476112] [CFGD REGISTER: PI320b] [EMBASE: 617708689]">Martiniano 2017</a>) and listed one trial as awaiting classification (<a href="./references#CD010004-bbs2-0003" title="BillerJA , EagleG , McGinnisJP , MicioniL , DaleyCL , WinthropKL , et al. Efficacy of liposomal amikacin for inhalation (LAI) in achieving nontuberculous mycobacteria (NTM) culture negativity in patients whose lung infection is refractory to guideline-based therapy. American Journal of Respiratory and Critical Care Medicine2015;191 Suppl:no pagination. [CENTRAL: 1136597] [CFGD REGISTER: PI281e] [EMBASE: 72054175]NCT01315236. Arikace® for Nontuberculous Mycobacteria. www.clinicaltrials.gov/ct2/show/NCT01315236?term=arikace&amp;rank=4 (accessed 01 October 2012). [CLINICALTRIALS.GOV IDENTIFIER: NCT01315236] OlivierKN , EagleG , McGinnis IIJP , MicioniL , DaleyCL , WinthropKL , et al. Randomized, double-blind, placebo-controlled, open-label study of liposomal amikacin for inhalation (LAI) in patients with recalcitrant nontuberculous mycobacterial lung disease (NTM-LD) [abstract]. Pediatric Pulmonology2014;49 Suppl 38:321, Abstract no: 293. [CENTRAL: 1012528] [CFGD REGISTER: PI281a] OlivierKN , EagleG , McGinnisJP , MicioniL , DaleyCL , WinthropKL , et al. Randomized, double-blind (DB), placebo-controlled study and open-label (OL) extension of liposomal amikacin for inhalation (LAI) in patients with refractory nontuberculous mycobacterial (NTM) lung disease (LD) [abstract]. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society2015;14 Suppl 1:S3, Abstract no: WS02.3. [CENTRAL: 1099086] [CFGD REGISTER: PI281b] OlivierKN , GriffithDE , EagleG , McGinnisJP , MicioniL , LiuK , et al. Randomized trial of liposomal amikacin for inhalation in nontuberculous mycobacterial lung disease. American Journal of Respiratory and Critical Care Medicine2017;195(6):814-23. [CFGD REGISTER: PI281g] OlivierKN , GuptaR , DaleyCL , WinthropKL , RuossS , Addrizzo-HarrisDJ , et al. A randomized, double-blind, placebo-controlled study of liposomal Amikacin for inhalation (Arikace) in patients with recalcitrant nontuberculous mycobacterial lung disease. American Journal of Respiratory and Critical Care Medicine2014;189:C27. [ABSTRACT NO.: A4126] [CFGD REGISTER: PI281f] RuossSJ , EagleG , McGinnisJP , MicioniL , DaleyCL , WinthropKL , et al. Analysis of functional exercise capacity (via the six-minute walk test [6MWT]) and culture negativity in patients with nontuberculous mycobacteria (NTM) lung infection refractory to guideline-based therapy treated with liposomal amikacin for inhalation (LAI). American Journal of Respiratory and Critical Care Medicine2015;191 Suppl:no pagination. [CENTRAL: 1136596] [CFGD REGISTER: PI281d] [EMBASE: 72054176]WinthropKL , EagleG , McGinnisJP , MicioniL , DaleyCL , RuossSJ , et al. Subgroup analyses of baseline demographics and efficacy in patients with refractory nontuberculous mycobacteria (NTM) lung infection treated with liposomal amikacin for inhalation (LAI). American Journal of Respiratory and Critical Care Medicine2015;191 Suppl:no pagination. [CENTRAL: 1136598] [CFGD REGISTER: PI281c] [EMBASE: 72054174]">Olivier 2017</a>). </p> </section> <section id="CD010004-sec-0048"> <h4 class="title">Excluded studies</h4> <p>We have excluded two studies (<a href="./references#CD010004-bbs2-0001" title="NCT04294043. IV gallium study for patients with cystic fibrosis who have NTM (ABATE Study) (ABATE) [A Phase 1b, Multi-center Study of Intravenous (IV) Gallium Nitrate in Patients With Cystic Fibrosis (CF) Who Are Colonized With Nontuberculous Mycobacteria (NTM) (The ABATE Study)]. www.clinicaltrials.gov/ct2/show/NCT04294043 (first posted 03 March 2020). ">ABATE</a>; <a href="./references#CD010004-bbs2-0002" title="MartinianoS , WagnerB , BrennanL , WempeM , AndersonP , NickJ , et al. Pharmacokinetics of oral mac antibiotics in cystic fibrosis. American Journal of Respiratory and Critical Care Medicine2017;195:A4842. [CENTRAL: CN-01476112] [CFGD REGISTER: PI320a] [EMBASE: 617708689]MartinianoS , WagnerB , BrennanL , WempeM , AndersonP , NickJ , et al. Pharmacokinetics of oral mac antibiotics in cystic fibrosis. Journal of Cystic Fibrosis2017;16 Suppl 1:S52. [ABSTRACT NO.: EPS7.2] [CENTRAL: CN-01476112] [CFGD REGISTER: PI320b] [EMBASE: 617708689]">Martiniano 2017</a>). One a study of intravenous gallium nitrate in people with CF has been registered but is not yet recruiting; however we have excluded this study as all participants received the same intervention, so no comparison is possible (<a href="./references#CD010004-bbs2-0001" title="NCT04294043. IV gallium study for patients with cystic fibrosis who have NTM (ABATE Study) (ABATE) [A Phase 1b, Multi-center Study of Intravenous (IV) Gallium Nitrate in Patients With Cystic Fibrosis (CF) Who Are Colonized With Nontuberculous Mycobacteria (NTM) (The ABATE Study)]. www.clinicaltrials.gov/ct2/show/NCT04294043 (first posted 03 March 2020). ">ABATE</a>). </p> <p>The second excluded study is a comparison of an intervention in people with CF and healthy controls; all CF participants were given the same intervention (intravenous gallium nitrate) so again no comparison is possible (<a href="./references#CD010004-bbs2-0002" title="MartinianoS , WagnerB , BrennanL , WempeM , AndersonP , NickJ , et al. Pharmacokinetics of oral mac antibiotics in cystic fibrosis. American Journal of Respiratory and Critical Care Medicine2017;195:A4842. [CENTRAL: CN-01476112] [CFGD REGISTER: PI320a] [EMBASE: 617708689]MartinianoS , WagnerB , BrennanL , WempeM , AndersonP , NickJ , et al. Pharmacokinetics of oral mac antibiotics in cystic fibrosis. Journal of Cystic Fibrosis2017;16 Suppl 1:S52. [ABSTRACT NO.: EPS7.2] [CENTRAL: CN-01476112] [CFGD REGISTER: PI320b] [EMBASE: 617708689]">Martiniano 2017</a>). </p> </section> <section id="CD010004-sec-0049"> <h4 class="title">Studies awaiting classification</h4> <p>One randomized controlled trial identified has been completed and published (<a href="./references#CD010004-bbs2-0003" title="BillerJA , EagleG , McGinnisJP , MicioniL , DaleyCL , WinthropKL , et al. Efficacy of liposomal amikacin for inhalation (LAI) in achieving nontuberculous mycobacteria (NTM) culture negativity in patients whose lung infection is refractory to guideline-based therapy. American Journal of Respiratory and Critical Care Medicine2015;191 Suppl:no pagination. [CENTRAL: 1136597] [CFGD REGISTER: PI281e] [EMBASE: 72054175]NCT01315236. Arikace® for Nontuberculous Mycobacteria. www.clinicaltrials.gov/ct2/show/NCT01315236?term=arikace&amp;rank=4 (accessed 01 October 2012). [CLINICALTRIALS.GOV IDENTIFIER: NCT01315236] OlivierKN , EagleG , McGinnis IIJP , MicioniL , DaleyCL , WinthropKL , et al. Randomized, double-blind, placebo-controlled, open-label study of liposomal amikacin for inhalation (LAI) in patients with recalcitrant nontuberculous mycobacterial lung disease (NTM-LD) [abstract]. Pediatric Pulmonology2014;49 Suppl 38:321, Abstract no: 293. [CENTRAL: 1012528] [CFGD REGISTER: PI281a] OlivierKN , EagleG , McGinnisJP , MicioniL , DaleyCL , WinthropKL , et al. Randomized, double-blind (DB), placebo-controlled study and open-label (OL) extension of liposomal amikacin for inhalation (LAI) in patients with refractory nontuberculous mycobacterial (NTM) lung disease (LD) [abstract]. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society2015;14 Suppl 1:S3, Abstract no: WS02.3. [CENTRAL: 1099086] [CFGD REGISTER: PI281b] OlivierKN , GriffithDE , EagleG , McGinnisJP , MicioniL , LiuK , et al. Randomized trial of liposomal amikacin for inhalation in nontuberculous mycobacterial lung disease. American Journal of Respiratory and Critical Care Medicine2017;195(6):814-23. [CFGD REGISTER: PI281g] OlivierKN , GuptaR , DaleyCL , WinthropKL , RuossS , Addrizzo-HarrisDJ , et al. A randomized, double-blind, placebo-controlled study of liposomal Amikacin for inhalation (Arikace) in patients with recalcitrant nontuberculous mycobacterial lung disease. American Journal of Respiratory and Critical Care Medicine2014;189:C27. [ABSTRACT NO.: A4126] [CFGD REGISTER: PI281f] RuossSJ , EagleG , McGinnisJP , MicioniL , DaleyCL , WinthropKL , et al. Analysis of functional exercise capacity (via the six-minute walk test [6MWT]) and culture negativity in patients with nontuberculous mycobacteria (NTM) lung infection refractory to guideline-based therapy treated with liposomal amikacin for inhalation (LAI). American Journal of Respiratory and Critical Care Medicine2015;191 Suppl:no pagination. [CENTRAL: 1136596] [CFGD REGISTER: PI281d] [EMBASE: 72054176]WinthropKL , EagleG , McGinnisJP , MicioniL , DaleyCL , RuossSJ , et al. Subgroup analyses of baseline demographics and efficacy in patients with refractory nontuberculous mycobacteria (NTM) lung infection treated with liposomal amikacin for inhalation (LAI). American Journal of Respiratory and Critical Care Medicine2015;191 Suppl:no pagination. [CENTRAL: 1136598] [CFGD REGISTER: PI281c] [EMBASE: 72054174]">Olivier 2017</a>). This phase 2, randomized, double‐blind controlled trial included adults (both with and without CF) who met criteria for pulmonary non‐tuberculous mycobacterial disease defined by the ATS and the IDSA. Participants had received ongoing multi‐drug treatment (based on ATS and IDSA guidelines) for at least six months prior to screening and had persistently positive cultures for <i>M avium</i> complex or <i>M abscessus</i>. Participants were randomized 1:1 to either liposomal amikacin for inhalation at a dose of 590 mg or placebo (empty liposomes) once daily via the PARI Investigational eFlow<sup>®</sup> Nebulizer; this regimen was added to their ongoing stable multi‐drug regimen for 84 days. At the end of this period, participants could consent to receive open‐label treatment with daily liposomal amikacin inhaled and their background regimen for an additional 84 days. The primary endpoint was the change from baseline to day 84 on a semi‐quantitative mycobacterial growth scale. Other endpoints included sputum conversion, 6‐minute walk distance and adverse events. The modified intent‐to‐treat population included 89 participants (liposomal amikacin for inhalation n = 44; placebo n = 45); 19% of participants had CF, 64% had predominantly <i>M avium</i> complex infection and 36% had predominantly <i>M abscessus</i> infection. </p> </section> </section> <section id="CD010004-sec-0050"> <h3 class="title">Risk of bias in included studies</h3> <p>No trials have yet been included in this review.</p> </section> <section id="CD010004-sec-0051"> <h3 class="title" id="CD010004-sec-0051">Effects of interventions</h3> <p>No trials have yet been included in this review.</p> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD010004-sec-0052" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD010004-sec-0052"></div> <section id="CD010004-sec-0053"> <h3 class="title" id="CD010004-sec-0053">Summary of main results</h3> <p>We have identified one randomized controlled trial which has been completed but it included both individuals with and without CF and therefore could not yet be included in this review (<a href="./references#CD010004-bbs2-0003" title="BillerJA , EagleG , McGinnisJP , MicioniL , DaleyCL , WinthropKL , et al. Efficacy of liposomal amikacin for inhalation (LAI) in achieving nontuberculous mycobacteria (NTM) culture negativity in patients whose lung infection is refractory to guideline-based therapy. American Journal of Respiratory and Critical Care Medicine2015;191 Suppl:no pagination. [CENTRAL: 1136597] [CFGD REGISTER: PI281e] [EMBASE: 72054175]NCT01315236. Arikace® for Nontuberculous Mycobacteria. www.clinicaltrials.gov/ct2/show/NCT01315236?term=arikace&amp;rank=4 (accessed 01 October 2012). [CLINICALTRIALS.GOV IDENTIFIER: NCT01315236] OlivierKN , EagleG , McGinnis IIJP , MicioniL , DaleyCL , WinthropKL , et al. Randomized, double-blind, placebo-controlled, open-label study of liposomal amikacin for inhalation (LAI) in patients with recalcitrant nontuberculous mycobacterial lung disease (NTM-LD) [abstract]. Pediatric Pulmonology2014;49 Suppl 38:321, Abstract no: 293. [CENTRAL: 1012528] [CFGD REGISTER: PI281a] OlivierKN , EagleG , McGinnisJP , MicioniL , DaleyCL , WinthropKL , et al. Randomized, double-blind (DB), placebo-controlled study and open-label (OL) extension of liposomal amikacin for inhalation (LAI) in patients with refractory nontuberculous mycobacterial (NTM) lung disease (LD) [abstract]. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society2015;14 Suppl 1:S3, Abstract no: WS02.3. [CENTRAL: 1099086] [CFGD REGISTER: PI281b] OlivierKN , GriffithDE , EagleG , McGinnisJP , MicioniL , LiuK , et al. Randomized trial of liposomal amikacin for inhalation in nontuberculous mycobacterial lung disease. American Journal of Respiratory and Critical Care Medicine2017;195(6):814-23. [CFGD REGISTER: PI281g] OlivierKN , GuptaR , DaleyCL , WinthropKL , RuossS , Addrizzo-HarrisDJ , et al. A randomized, double-blind, placebo-controlled study of liposomal Amikacin for inhalation (Arikace) in patients with recalcitrant nontuberculous mycobacterial lung disease. American Journal of Respiratory and Critical Care Medicine2014;189:C27. [ABSTRACT NO.: A4126] [CFGD REGISTER: PI281f] RuossSJ , EagleG , McGinnisJP , MicioniL , DaleyCL , WinthropKL , et al. Analysis of functional exercise capacity (via the six-minute walk test [6MWT]) and culture negativity in patients with nontuberculous mycobacteria (NTM) lung infection refractory to guideline-based therapy treated with liposomal amikacin for inhalation (LAI). American Journal of Respiratory and Critical Care Medicine2015;191 Suppl:no pagination. [CENTRAL: 1136596] [CFGD REGISTER: PI281d] [EMBASE: 72054176]WinthropKL , EagleG , McGinnisJP , MicioniL , DaleyCL , RuossSJ , et al. Subgroup analyses of baseline demographics and efficacy in patients with refractory nontuberculous mycobacteria (NTM) lung infection treated with liposomal amikacin for inhalation (LAI). American Journal of Respiratory and Critical Care Medicine2015;191 Suppl:no pagination. [CENTRAL: 1136598] [CFGD REGISTER: PI281c] [EMBASE: 72054174]">Olivier 2017</a>). </p> <p>This trial of liposomal amikacin for inhalation in adults (19% of whom had CF) who met defined criteria for pulmonary NTM disease, had received ongoing multi‐drug treatment for at least six months and had persistently positive cultures for <i>M avium</i> complex or <i>M abscessus</i> (<a href="./references#CD010004-bbs2-0003" title="BillerJA , EagleG , McGinnisJP , MicioniL , DaleyCL , WinthropKL , et al. Efficacy of liposomal amikacin for inhalation (LAI) in achieving nontuberculous mycobacteria (NTM) culture negativity in patients whose lung infection is refractory to guideline-based therapy. American Journal of Respiratory and Critical Care Medicine2015;191 Suppl:no pagination. [CENTRAL: 1136597] [CFGD REGISTER: PI281e] [EMBASE: 72054175]NCT01315236. Arikace® for Nontuberculous Mycobacteria. www.clinicaltrials.gov/ct2/show/NCT01315236?term=arikace&amp;rank=4 (accessed 01 October 2012). [CLINICALTRIALS.GOV IDENTIFIER: NCT01315236] OlivierKN , EagleG , McGinnis IIJP , MicioniL , DaleyCL , WinthropKL , et al. Randomized, double-blind, placebo-controlled, open-label study of liposomal amikacin for inhalation (LAI) in patients with recalcitrant nontuberculous mycobacterial lung disease (NTM-LD) [abstract]. Pediatric Pulmonology2014;49 Suppl 38:321, Abstract no: 293. [CENTRAL: 1012528] [CFGD REGISTER: PI281a] OlivierKN , EagleG , McGinnisJP , MicioniL , DaleyCL , WinthropKL , et al. Randomized, double-blind (DB), placebo-controlled study and open-label (OL) extension of liposomal amikacin for inhalation (LAI) in patients with refractory nontuberculous mycobacterial (NTM) lung disease (LD) [abstract]. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society2015;14 Suppl 1:S3, Abstract no: WS02.3. [CENTRAL: 1099086] [CFGD REGISTER: PI281b] OlivierKN , GriffithDE , EagleG , McGinnisJP , MicioniL , LiuK , et al. Randomized trial of liposomal amikacin for inhalation in nontuberculous mycobacterial lung disease. American Journal of Respiratory and Critical Care Medicine2017;195(6):814-23. [CFGD REGISTER: PI281g] OlivierKN , GuptaR , DaleyCL , WinthropKL , RuossS , Addrizzo-HarrisDJ , et al. A randomized, double-blind, placebo-controlled study of liposomal Amikacin for inhalation (Arikace) in patients with recalcitrant nontuberculous mycobacterial lung disease. American Journal of Respiratory and Critical Care Medicine2014;189:C27. [ABSTRACT NO.: A4126] [CFGD REGISTER: PI281f] RuossSJ , EagleG , McGinnisJP , MicioniL , DaleyCL , WinthropKL , et al. Analysis of functional exercise capacity (via the six-minute walk test [6MWT]) and culture negativity in patients with nontuberculous mycobacteria (NTM) lung infection refractory to guideline-based therapy treated with liposomal amikacin for inhalation (LAI). American Journal of Respiratory and Critical Care Medicine2015;191 Suppl:no pagination. [CENTRAL: 1136596] [CFGD REGISTER: PI281d] [EMBASE: 72054176]WinthropKL , EagleG , McGinnisJP , MicioniL , DaleyCL , RuossSJ , et al. Subgroup analyses of baseline demographics and efficacy in patients with refractory nontuberculous mycobacteria (NTM) lung infection treated with liposomal amikacin for inhalation (LAI). American Journal of Respiratory and Critical Care Medicine2015;191 Suppl:no pagination. [CENTRAL: 1136598] [CFGD REGISTER: PI281c] [EMBASE: 72054174]">Olivier 2017</a>). In addition to their ongoing multi‐drug regimen, participants were randomized to inhaled liposomal amikacin or placebo for 84 days. Although the primary endpoint of a reduction in semi‐quantitative mycobacterial growth was not achieved, a greater proportion of participants in the liposomal amikacin group (32%) demonstrated sputum conversion (at least one negative mycobacterial sputum culture) than in the placebo group (9%) (P = 0.006); however, most of those in whom sputum conversion was observed did not have CF and were infected with <i>M avium</i> complex rather than <i>M abscessus</i> infection. Those in the liposomal amikacin group also had a greater improvement in the 6‐minute walk test at day 84 (P = 0.017). </p> <p>We are waiting for data for just the participants with CF before including this trial in the review. </p> </section> <section id="CD010004-sec-0054"> <h3 class="title" id="CD010004-sec-0054">Overall completeness and applicability of evidence</h3> <p>The only identified randomized controlled trial to date was in adults only (<a href="./references#CD010004-bbs2-0003" title="BillerJA , EagleG , McGinnisJP , MicioniL , DaleyCL , WinthropKL , et al. Efficacy of liposomal amikacin for inhalation (LAI) in achieving nontuberculous mycobacteria (NTM) culture negativity in patients whose lung infection is refractory to guideline-based therapy. American Journal of Respiratory and Critical Care Medicine2015;191 Suppl:no pagination. [CENTRAL: 1136597] [CFGD REGISTER: PI281e] [EMBASE: 72054175]NCT01315236. Arikace® for Nontuberculous Mycobacteria. www.clinicaltrials.gov/ct2/show/NCT01315236?term=arikace&amp;rank=4 (accessed 01 October 2012). [CLINICALTRIALS.GOV IDENTIFIER: NCT01315236] OlivierKN , EagleG , McGinnis IIJP , MicioniL , DaleyCL , WinthropKL , et al. Randomized, double-blind, placebo-controlled, open-label study of liposomal amikacin for inhalation (LAI) in patients with recalcitrant nontuberculous mycobacterial lung disease (NTM-LD) [abstract]. Pediatric Pulmonology2014;49 Suppl 38:321, Abstract no: 293. [CENTRAL: 1012528] [CFGD REGISTER: PI281a] OlivierKN , EagleG , McGinnisJP , MicioniL , DaleyCL , WinthropKL , et al. Randomized, double-blind (DB), placebo-controlled study and open-label (OL) extension of liposomal amikacin for inhalation (LAI) in patients with refractory nontuberculous mycobacterial (NTM) lung disease (LD) [abstract]. Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society2015;14 Suppl 1:S3, Abstract no: WS02.3. [CENTRAL: 1099086] [CFGD REGISTER: PI281b] OlivierKN , GriffithDE , EagleG , McGinnisJP , MicioniL , LiuK , et al. Randomized trial of liposomal amikacin for inhalation in nontuberculous mycobacterial lung disease. American Journal of Respiratory and Critical Care Medicine2017;195(6):814-23. [CFGD REGISTER: PI281g] OlivierKN , GuptaR , DaleyCL , WinthropKL , RuossS , Addrizzo-HarrisDJ , et al. A randomized, double-blind, placebo-controlled study of liposomal Amikacin for inhalation (Arikace) in patients with recalcitrant nontuberculous mycobacterial lung disease. American Journal of Respiratory and Critical Care Medicine2014;189:C27. [ABSTRACT NO.: A4126] [CFGD REGISTER: PI281f] RuossSJ , EagleG , McGinnisJP , MicioniL , DaleyCL , WinthropKL , et al. Analysis of functional exercise capacity (via the six-minute walk test [6MWT]) and culture negativity in patients with nontuberculous mycobacteria (NTM) lung infection refractory to guideline-based therapy treated with liposomal amikacin for inhalation (LAI). American Journal of Respiratory and Critical Care Medicine2015;191 Suppl:no pagination. [CENTRAL: 1136596] [CFGD REGISTER: PI281d] [EMBASE: 72054176]WinthropKL , EagleG , McGinnisJP , MicioniL , DaleyCL , RuossSJ , et al. Subgroup analyses of baseline demographics and efficacy in patients with refractory nontuberculous mycobacteria (NTM) lung infection treated with liposomal amikacin for inhalation (LAI). American Journal of Respiratory and Critical Care Medicine2015;191 Suppl:no pagination. [CENTRAL: 1136598] [CFGD REGISTER: PI281c] [EMBASE: 72054174]">Olivier 2017</a>). To date, we do not have access to the data for those participants with CF, it is therefore not possible to determine the relevance of these findings to the CF population. </p> </section> <section id="CD010004-sec-0055"> <h3 class="title" id="CD010004-sec-0055">Agreements and disagreements with other studies or reviews</h3> <p>Traditionally, antimicrobial therapy of NTM lung infection (including in people with CF) has been guided by protocols summarized in the statement endorsed by the American Thoracic Society (ATS) and the Infectious Diseases Society of America (IDSA) (<a href="./references#CD010004-bbs2-0032" title="Griffith DE,  AksamitT ,  Brown-ElliottBA ,  CatanzaroA ,  DaleyC ,  GordinF , et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. American Journal of Respiratory and Critical Care Medicine2007;175(4):367-416. [PMID: 17277290]">Griffith 2007</a>). </p> <p>Most data are available for <i>M avium</i> complex and these recommendations are based on evidence with a highest grade of II (evidence from at least one well‐designed clinical trial without randomization). The initial controlled‐treatment studies were undertaken using only first‐line anti‐tuberculosis (TB) drugs, which have 10 to 100 times less in vitro activity against <i>M avium</i> complex than against <i>Mycobacterium tuberculosis.</i> The Research Committee of the British Thoracic Society conducted the first randomized controlled trial of 75 participants with <i>M avium</i> complex pulmonary disease. Participants were randomized to two years of either rifampicin and ethambutol or to rifampicin, ethambutol and isoniazid (<a href="./references#CD010004-bbs2-0008" title="British Thoracic Society. First randomised trial of treatments for pulmonary disease caused by M avium intracellulare, M malmoense, and M xenopi in HIV negative patients: rifampicin, ethambutol and isoniazid versus rifampicin and ethambutol. Thorax2001;56(3):167-72.">British Thoracic Society 2001</a>; <a href="./references#CD010004-bbs2-0009" title="British Thoracic Society. Pulmonary disease caused by Mycobacterium avium-intracellulare in HIV-negative patients: five-year follow-up of patients receiving standardised treatment. International Journal of Tuberculosis and Lung Disease2002;6(7):628-34.">British Thoracic Society 2002</a>). Although two thirds of enrolled participants had co‐existing lung disease, it was not specified if any of them had CF. In this trial, there were fewer treatment failures or relapses with the rifampicin, ethambutol and isoniazid regimen compared to the rifampicin and ethambutol regimen (16% versus 41% respectively, P = 0.033). However, there was a suggestion that the rifampicin, ethambutol and isoniazid regimen was associated with higher death rates overall. The advent of the newer macrolides, clarithromycin and azithromycin, was a significant advancement in the treatment of pulmonary disease due to <i>M avium</i> complex, as these drugs have good in vitro and clinical activity against <i>M avium</i> complex (<a href="./references#CD010004-bbs2-0032" title="Griffith DE,  AksamitT ,  Brown-ElliottBA ,  CatanzaroA ,  DaleyC ,  GordinF , et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. American Journal of Respiratory and Critical Care Medicine2007;175(4):367-416. [PMID: 17277290]">Griffith 2007</a>). Clinical studies of macrolide use with traditional anti‐TB drugs have shown superior sputum conversion rates compared to historical controls (<a href="./references#CD010004-bbs2-0031" title="GriffithDE , BrownBA , GirardWM , MurphyDT , Wallace RJ Jr. Azithromycin activity against Mycobacterium avium complex lung disease in patients who were not infected with human immunodeficiency virus. Clinical Infectious Diseases1996;23(5):983-9.">Griffith 1996</a>; <a href="./references#CD010004-bbs2-0060" title="Wallace RJ Jr, BrownBA , GriffithDE , GirardWM , MurphyDT , OnyiGO , et al. Initial clarithromycin monotherapy for Mycobacterium avium-intracellulare complex lung disease. American Journal of Respiratory and Critical Care Medicine1994;149(5):1335-41.">Wallace 1994</a>; <a href="./references#CD010004-bbs2-0061" title="Wallace RJ Jr, BrownBA , GriffithDE , GirardWM , MurphyDT . Clarithromycin regimens for pulmonary Mycobacterium avium complex. The first 50 patients. American Journal of Respiratory and Critical Care Medicine1996;153(6 Pt 1):1766-72.">Wallace 1996</a>). However, in a recent two‐year trial of mycobacterial lung disease, clarithromycin was compared to ciprofloxacin as alternative third drugs to be added to rifampicin and ethambutol and did not demonstrate any superiority in terms of clinical outcomes in people infected with <i>M avium</i> complex (<a href="./references#CD010004-bbs2-0037" title="Jenkins PA,  CampbellIA ,  BanksJ ,  GelderCM ,  PrescottRJ ,  SmithAP . Clarithromycin vs ciprofloxacin as adjuncts to rifampicin and ethambutol in treating opportunist mycobacterial lung diseases and an assessment of Mycobacterium vaccae immunotherapy. Thorax2008;63(7):627-34.">Jenkins 2008</a>). </p> <p>The other NTM species commonly isolated from the respiratory tract of people with CF is <i>M abscessus</i> . In contrast to <i>M avium</i> complex, <i>M abscessus</i> is uniformly resistant to the standard anti‐tuberculous agents (<a href="./references#CD010004-bbs2-0032" title="Griffith DE,  AksamitT ,  Brown-ElliottBA ,  CatanzaroA ,  DaleyC ,  GordinF , et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. American Journal of Respiratory and Critical Care Medicine2007;175(4):367-416. [PMID: 17277290]">Griffith 2007</a>). There are few comparative trials of differing antimicrobial interventions for the treatment of pulmonary NTM disease due to <i>M abscessus.</i> Our search identified only one randomized, placebo‐controlled trial testing liposomal amikacin for inhalation (Olivier 2017). Liposomal amikacin is an aminoglycoside drug that has been enveloped in a spherical phospholipid bilayer known as a liposome. This formulation of the drug can be delivered via inhalation to the lower airways where the lipid bilayer fuses with the bacterial cell membrane, allowing delivery of the drug into the cell (<a href="./references#CD010004-bbs2-0006" title="BeaulacC , Clement-MajorS , HawariJ , LagaceJ . In vitro kinetics of drug release and pulmonary retention of microencapsulated antibiotic in liposomal formulations in relation to the lipid composition. Journal of Microencapsulation1997;14(3):335-48.">Beaulac 1997</a>; <a href="./references#CD010004-bbs2-0054" title="SachetelliS , KhalilH , ChenT , BeaulacC , SenechalS , LagaceJ . Demonstration of a fusion mechanism between a fluid bactericidal liposomal formulation and bacterial cells. Biochimica et Biophysica Acta2000;1463(2):254-66.">Sachetelli 2000</a>). The trial did not achieve its primary endpoint (reduction in semi‐quantitative mycobacterial growth), but showed sputum conversion (at least one negative mycobacterial sputum culture) (P=0.006) and improvement in 6‐minute walk test (P=0.017) at day 84 in the liposomal amikacin group compared to the placebo group. Unfortunately most participants in whom sputum conversion was observed did not have CF and were infected with <i>M avium</i> complex rather than <i>M abscessus</i> infection. </p> </section> </section> </section> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD010004.pub5&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"/> </noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD010004-note-0009">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD010004-note-0007">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD010004-note-0008">Français</a> </li> <li class="section-language"> <a class="" href="ko#CD010004-note-0005">한국어</a> </li> <li class="section-language"> <a class="" href="ms#CD010004-note-0006">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD010004-note-0003">简体中文</a> </li> <li class="section-language"> <a class="" href="zh_HANT#CD010004-note-0004">繁體中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"/> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"/> </a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br/> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738735355000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738735355000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010004\x2epub5\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010004\x2epub5\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010004\x2epub5\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010004\x2epub5"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010004\x2epub5\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010004\x2epub5\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010004\x2epub5\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010004\x2epub5\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010004\x2epub5\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010004\x2epub5"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010004\x2epub5\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010004\x2epub5\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010004\x2epub5\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010004\x2epub5"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010004\x2epub5\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010004\x2epub5\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010004\x2epub5\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010004\x2epub5"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=bzu3XIhG&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010004.pub5&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD010004.pub5';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD010004.pub5/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD010004.pub5/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010004.pub5%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"/> <span class="taglib-text hide-accessible">Sign In</span> </span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740727654524"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD010004.pub5/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"/> <span class="taglib-text hide-accessible">Sign In</span> </span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740727654528"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD010004.pub5/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918eb159ba2b936d',t:'MTc0MDcyNzY1NC4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 